Asian Pharma Groups Agree to Ensure Smooth Drug Reviews amid COVID-19 Crisis

April 16, 2021
JPMA President Joji Nakayama Gives Briefing on APAC Meeting Initiatives to harmonize regulatory approval systems in Asia continue unabated despite the COVID-19 pandemic raging on across the world. The Asia Partnership Conference of Pharmaceutical Associations (APAC) agreed on the importance...read more